Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Adam Taylor, Professor of Anatomy, Lancaster University

The hidden risks of grey-market peptides – why women face greater danger

Alan Crosthwaite/Shutterstock.com

A wave of unregulated peptides is sweeping the wellness world, sold online with bold promises about muscle gain, anti-ageing and fat loss. But concern is growing about side-effects, and almost nobody is asking whether these substances affect men and women in the same way. The evidence suggests they do not.

Women are one and a half to two times more likely than men to suffer a bad reaction to a drug, partly because more women take prescription medicines in the first place. They live longer than men on average and are more prone to conditions requiring long-term medication, such as osteoporosis, lupus and rheumatoid arthritis, and tend to experience more severe symptoms when they do. That raises the odds of drug interactions before biology even comes into play. Differences in how the body breaks down and clears drugs from the body, along with hormonal and immune variation, stack the risk further.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.